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Summary
Purpose:  To  determine  the  rate  of  device-associated  healthcare-associated  infec-
tions  (DA-HAIs)  at  a  respiratory  intensive  care  unit  (RICU)  and  in  the  pediatric
intensive  care  units  (PICUs)  of  member  hospitals  of  the  International  Nosocomial
Infection  Control  Consortium  (INICC)  in  Egypt.
Materials  and  Methods:  A  prospective  cohort  DA-HAI  surveillance  study  was  con-
ducted  from  December  2008  to  July  2010  by  applying  the  methodology  of  the  INICC
and  the  deﬁnitions  of  the  NHSN-CDC.Developing countries;
Intensive care unit;
Pediatric intensive care
unit
Results:  In  the  RICU,  473  patients  were  hospitalized  for  2930  d  and  acquired  155  DA-
HAIs,  with  an  overall  rate  of  32.8%.  There  were  52.9  DA-HAIs  per  1000  ICU-days.  In
the  PICUs,  143  patients  were  hospitalized  for  1535  d  and  acquired  35  DA-HAIs,  with
an  overall  rate  of  24.5%.  There  were  22.8  DA-HAIs  per  1000  ICU-days.  The  central
line-associated  blood  stream  infection  (CLABSI)  rate  was  22.5  per  1000  line-days  in
the  RICU  and  18.8  in  the  PICUs;  the  ventilator-associated  pneumonia  (VAP)  rate  was
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n  an  increasingly  large  amount  of  scientiﬁc  liter-
ture,  DA-HAIs  are  considered  the  principal  threat
o patient  safety  in  the  ICU  and  are  among  the  main
auses of  patient  morbidity  and  mortality  [1,2].
In  industrialized  countries,  device-associated
ealthcare-associated  infection  (DA-HAI)  surveil-
ance in  the  intensive  care  unit  (ICU)  plays  a
ubstantial  role  in  hospital  infection  control  and
uality assurance  [3]  and  was  reported  by  the
enters  for  Disease  Control  and  Prevention  (CDC)
tudy  of  the  efﬁcacy  of  nosocomial  infection  con-
rol (SENIC)  as  an  efﬁcacious  tool  to  reduce  DA-HAIs
4].
The CDC’s  previous  National  Nosocomial  Infec-
ion Surveillance  System  (NNIS)  and  current
ational Healthcare  Safety  Network  (NHSN)  have
stablished  standardized  criteria  for  DA-HAI  surveil-
ance [5,6].  This  standardized  surveillance  method
llows for  the  determination  of  DA-HAI  rates  per
000 device-days,  which  can  be  used  as  benchmarks
mong healthcare  centers,  and  provides  infection
ontrol practitioners  (ICPs)  with  an  in-depth  look  at
he institutional  problems  they  are  confronted  with
o they  can  design  an  effective  strategy  to  solve
hem.
However,  in  the  context  of  an  expanded  frame-
ork for  DA-HAI  control,  most  of  the  relevant
tudies of  ICU-acquired  infections  have  been
arried out  in  industrialized  countries  [7].  In  devel-
ping countries,  in  contrast,  few  published  studies
ave reported  DA-HAI  rates  using  standardized  def-
nitions [8—15].
The  International  Nosocomial  Infection  Control
onsortium (INICC)  was  founded  in  1998,  when
elected  hospitals  from  Latin  America  were  invited
o participate  in  the  project  to  measure  DA-HAIs
sing standardized  deﬁnitions  and  methodology
16]. Subsequently,  other  hospitals  from  different
arts  of  the  world  joined  the  INICC.  Currently,  the
NICC comprises  a  worldwide  network  of  300  hospi-
als from  40  countries  in  Latin  America,  Asia,  Africa
nd Europe  [12].
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s  in  the  RICU  and  31.8  in  the  PICUs;  and  the  catheter-
tion  (CAUTI)  rate  was  34.2  per  1000  catheter-days  in  the
CUs  in  Egypt  pose  greater  threats  to  patient  safety  than
nd  infection  control  programs,  including  surveillance  and
riority.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
On  a  monthly  basis,  healthcare  facilities  send
ata to  the  INICC,  which  are  then  entered  into
n international  database.  Member  hospitals  of the
NICC provide  general  medical  and  surgical  inpa-
ient services  to  adults  and  children  hospitalized
n ICUs.
The  ﬁndings  of  this  study  on  Egypt  DA-HAI  rates
orm an  integral  part  of  the  INICC  and  reﬂect  the
utcome  and  process  surveillance  data  that  were
ystematically  collected.
ethods
etting
he  study  was  carried  out  in  3  ICUs  in  three
ospitals in  two  cities  in  Egypt  from  December
008 to  July  2010.  Each  hospital  had  an  infection
ontrol team  (ICT)  with  a physician,  an  infec-
ion control  practitioner  (ICP)  with  at  least  one
ear of  experience  in  infection  control  (Table  1)
nd a microbiology  laboratory  to  perform  in  vitro
usceptibility  testing  of  clinical  isolates  using  stan-
ardized methods.  Every  hospital’s  institutional
eview board  agreed  to  the  study  protocol.  Patient
onﬁdentiality  was  protected  by  codifying  the
ecorded  information,  making  it identiﬁable  only  to
he ICT.
NICC methodology
he  INICC  surveillance  program  includes  two  com-
onents:  outcome  surveillance  (DA-HAI  rates  and
heir adverse  effects)  and  process  surveillance
adherence to  hand  hygiene  and  other  basic  pre-
entive infection  control  practices)  [16].
Investigators  were  required  to  complete  out-
ome and  process  surveillance  forms  at  their
ospitals, which  were  then  sent  to  the  INICC  head-
uarters  ofﬁce  in  Buenos  Aires  for  their  monthly
nalysis.
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Table  1  Features  of  the  International  Nosocomial  Infection  Control  Consortium  hospitals  and  intensive  care  units.
Variable  Hospital  A  Hospital  B  Hospital  C  Overall
Hospitals,  n  (%) 1 1  1  3
Academic  teaching  1  0  1  2  (66%)
Public  0  1  0  1  (33%)
Private  community 0  0  0  0
Hospital  number  of  beds 400 150  1000  400—1000
ICUs,  n 1 1 1 3
ICU  type PICU PICU RICU PICU  &  RICU
Surveillance  period 04/2009—09/2009  06/2010—07/2010  12/2008—12/2009  12/2008—07/2010
Range  of  experience  of
the  infection  control
practitioner,  y
1 3  2  1—3
Patients  studied,  n  119  24  473  616
Total  ICU  days,  d  1274  261  2930  6000
Device  usea
Ventilator  days,  d  510  57  1077  1644
Ventilator  use  0.40  0.22  0.37  0.27
Central  line  days,  d  794  112  1021  1927
Central  line  use  0.62  0.43  0.35  0.32
Urinary  catheter  days,  d 466 67  1551  2084
Urinary  catheter  use 0.37 0.26  0.53  0.35
ICU, intensive care unit; RICU, respiratory intensive care unit; PICU, pediatric intensive care unit; d, days.
a Device utilization (DU): DU ratios were calculated by dividing the total number of device-days by the total number of patient-
days. Device-days are the total number of days of exposure to the device (central line, ventilator, or urinary catheter) by all of
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Outcome surveillance
The  INICC  surveillance  program  applies  methods
and deﬁnitions  for  healthcare-associated  infections
(HAIs)  developed  by  the  U.S.  Centers  for  Disease
Control and  Prevention  (CDC)  for  the  NNIS/NHSN
program [6,17];  however,  the  INICC  methods  have
been adapted  to  the  setting  of  developing  countries
due to  their  different  socioeconomic  status  and  spe-
ciﬁc resource  limitations  [16].
Outcome  surveillance  includes  the  rates  of
CLAB, ventilator-associated  pneumonia  (VAP)  and
catheter-associated  urinary  tract  infection  (CAUTI)
per 1000  device-days,  the  microorganism  proﬁle,
and the  length  of  stay  and  mortality  in  ICUs.
Process surveillance
The  infection  control  and  prevention  strategies
implemented in  INICC  member  hospitals  are  based
on inexpensive  and  basic  evidence-based  measures,
including  outcome  surveillance,  process  surveil-
lance,  education  and  performance  feedback  on
outcome  surveillance  and  process  surveillance
[18—21].
Process surveillance  was  designed  to  assess
compliance with  easily  measurable  key  infec-
tion control  practices,  such  as  surveillance  of
m
r
c
oriod. Patient-days are the total number of days that patients
ompliance  rates  for  hand  hygiene  practices  and
peciﬁc measures  for  the  prevention  of  CLAB,  CAUTI
nd VAP  [16].  Hand  hygiene  compliance  by  health-
are workers  (HCWs),  based  on  the  frequency  with
hich hand  hygiene  is  performed  when  clearly  indi-
ated, is monitored  by  the  ICP  during  randomly
elected 1-h  observation  periods  three  times  per
eek. Although  HCWs  are  aware  that  hand  hygiene
ractices  are  regularly  monitored,  they  are  not
nformed  of  the  schedule  for  hand  hygiene  obser-
ations. Central  line  (CL)  care  compliance  is  also
onitored  and  recorded  ﬁve  days  per  week  through
he completion  of  surveillance  forms  that  eval-
ate  whether  infection  control  procedures  were
orrectly  carried  out  by  the  HCWs  [16].
eﬁnition of device-associated
ealthcare-associated infections
entilator-associated  pneumonia  (VAP).  Ventilator-
ssociated  pneumonia  is  indicated  in  a mechan-
cally  ventilated  patient  with  a  chest  radiograph
howing new  or  progressive  inﬁltrates,  consolida-
ion, cavitation,  or  pleural  effusion.  The  patient
ust also  meet  at  least  one  of  the  following  crite-
ia: new  onset  of  purulent  sputum  or  change  in
haracter  of  sputum;  organism  cultured  from  blood;
r isolation  of  an  etiologic  agent  from  a  specimen
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btained  by  tracheal  aspirate,  bronchial  brushing
r bronchoalveolar  lavage,  or  biopsy  [6].
Central line-associated  laboratory-conﬁrmed
loodstream  infection  (LCBI).  A  central  venous
atheter-associated  bloodstream  infection  is  lab-
ratory conﬁrmed  when  a  patient  with  a CVC  has
 recognized  pathogen  that  is  isolated  from  one
r more  percutaneous  blood  cultures  after  48  h
f vascular  catheterization  and  is  not  related  to
n infection  at  another  site.  The  patient  should
lso have  at  least  one  of  the  following  signs  or
ymptoms:  fever  (temperature  ≥  38 ◦C),  chills,  or
ypotension.  With  skin  commensals  (for  exam-
le, diphtheroids,  Bacillus  spp.,  Propionibacterium
pp., coagulase-negative  staphylococci,  or  micro-
occi), the  organism  is  cultured  from  two  or  more
lood  cultures  [6].
Clinical  sepsis.  A  central  line-associated  blood-
tream  infection  is  clinically  suspected  when  a
atient  with  a  CVC  has  at  least  one  of  the  following
linical signs  with  no  other  recognized  cause:  fever
temperature  ≥  38 ◦C),  hypotension  (systolic  blood
ressure  ≤  90  mmHg),  or  oliguria  (≤20  mL/h)  [6].
Catheter-associated  urinary  tract  infection
CAUTI). For  the  diagnosis  of  catheter-associated
rinary  tract  infection,  the  patient  must  meet  one
f two  criteria.  The  ﬁrst  criterion  is  satisﬁed  when
 patient  with  a  urinary  catheter  has  one  or  more  of
he following  symptoms  with  no  other  recognized
ause: fever  (temperature  ≥  38 ◦C),  urgency,  or
uprapubic  tenderness.  The  urine  culture  should
e positive  for  105 colony-forming  units  (CFUs)/mL
r more,  with  no  more  than  two  microorganisms
solated.  The  second  criterion  is  satisﬁed  when  a
atient with  a  urinary  catheter  has  at  least  two
f the  following  criteria  with  no  other  recognized
ause: positive  dipstick  analysis  for  leukocyte
sterase or  nitrate  and  pyuria  (≥10  leukocytes/mL)
6].
ulture techniques
entral  line-associated  bloodstream  infection
CLABSI). Central  lines  were  removed  aseptically,
nd the  distal  5  cm  of  the  catheter  was  cut  and
ultured using  a  standardized  semi-quantitative
ethod [22].  Concomitant  blood  cultures  were
rawn  percutaneously  in  all  cases.
Ventilator-associated  pneumonia  (VAP).  A  deep
racheal  aspirate  from  the  endotracheal  tube  was
ultured non-quantitatively  and  aerobically  and
ram stained.
Catheter-associated  urinary  tract  infection
CAUTI). A  urine  sample  was  aseptically  aspirated
rom the  sampling  port  of  the  urinary  catheter  and
ultured  quantitatively.
1
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In  all  cases,  standard  laboratory  methods  were
sed  to  identify  microorganisms,  and  a standard-
zed susceptibility  test  was  performed  [23].
evice-associated healthcare-associated
nfection  rate calculation
utcomes  measured  during  the  surveillance  period
ncluded  the  incidence  density  rate  of  CLABSIs
number of  cases  per  1000  central  line-days),
AUTIs (number  of  cases  per  1000  urinary  catheter-
ays)  and  VAP  (number  of  cases  per  1000
echanical ventilator-days).
DA-HAI  rates  of  VAP,  CLABSIs,  and  CAUTIs  per
000 device-days  were  calculated  by  dividing  the
otal number  of  DA-HAIs  by  the  total  number  of  spe-
iﬁc device-days  and  multiplying  the  result  by  1000
17].
Device utilization  (DU)  ratios  were  calculated  by
ividing the  total  number  of  device-days  by the
otal number  of  patient-days.  Device-days  are  the
otal number  of  days  of  exposure  to  the  device
central line,  ventilator,  or  urinary  catheter)  by  all
f the  patients  in  the  selected  population  during
he selected  time  period.  Patient-days  are  the  total
umber of  days  that  patients  were  in  the  ICU  during
he selected  time  period  [17].
tatistical analysis
piInfo®  version  6.04b  (CDC,  Atlanta,  GA)  and  SPSS
6.0 (SPSS  Inc.,  an  IBM  Company,  Chicago,  IL)  were
sed to  perform  the  data  analyses.
Baseline differences  among  rates  were  analyzed
sing the  chi-square  test  for  dichotomous  variables
nd a t-test  for  continuous  variables.  Relative  risk
RR) ratios,  95%  conﬁdence  intervals  (CIs)  and  P-
alues were  determined  for  all  outcomes.
esults
eatures of the population studied
e  recorded  473  patients  hospitalized  for  2930  days
n the  RICU.  These  patients  acquired  155  DA-HAIs,
ith an  overall  rate  of  32.8%  (95%  CI  28.5—37.2),
nd 52.9  (95%  CI  45.1—61.7)  DA-HAIs  per  1000
CU-days. In  the  PICUs,  we  recorded  143  patients
ospitalized for  1533  days.  These  patients  acquired
5 DA-HAIs,  with  an  overall  rate  of  24.5%  (95%  CI
7.7—32.4),  and  22.8  (95%  CI  15.9—31.6)  DA-HAIs
er 1000  ICU-days.
CLABSIs represented  20%  of  all  HAIs,  VAP  rep-
esented 52%,  and  CAUTIs  represented  28%.  The
398  O.  Rasslan  et  al.
Table  2  Device-associated  healthcare-associated  infections  per  1000  device-days:  ventilator-associated  pneumo-
nia,  central  line-associated  blood  stream  infection,  and  catheter-associated  urinary  tract  infection  in  the  pediatric
and  respiratory  intensive  care  unit.
Type  of
ICU
Infection
site
Device
type
Device-
days
DA-HAI  Distribution
of  DA-HAIs
(%)
Rate  per
100
patients  (%)
Rate  per  1000
device-days
PICU VAP MV 567 18  51.4  12.6 31.7  (95%  CI  19.9—49.8)
PICU CLABSI CL 906 15 48.6  11.9 18.8  (95%  CI  10.9—29.9)
PICU CAUTI UC 533 0 0.0  0.0  0.0
RICU  VAP  MV  1077  79  51%  16.7 73.4  (95%  CI  58.5—90.6)
RICU  CLABSI  CL  1021  23  15%  4.9  22.5  (95%  CI  14.3—33.6)
RICU  CAUTI  UC  1551  53  34%  11.2 34.2  (95%  CI  25.7—44.5)
VAP, ventilator-associated pneumonia; CLABSI, central line-associated blood stream infection; CAUTI, catheter-associated urinary
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individual  characteristics  of  each  ICU,  the  number
of patients  enrolled  in  the  study,  and  the  number
of ICU-days  are  shown  in  Table  1.  PICUs  collected
and sent  original  data  to  INICC  headquarters,  and
the RICU  collected  and  sent  aggregated  data  to  the
INICC.
Device utilization (DU) ratio
In  the  RICU,  the  device  utilization  ratio  was  0.37
for mechanical  ventilation,  0.35  for  CLs,  and  0.53
for urinary  catheters.  In  the  PICUs,  the  device  uti-
lization ratio  was  0.37  for  mechanical  ventilation,
0.59 for  CLs,  and  0.35  for  urinary  catheters.  Device
utilization  is  shown  in  Table  1.
Hand hygiene compliance
The  total  number  of  HH  opportunities  observed  in
the PICUs  was  140.  The  HH  compliance  rate  was
47.1% (95%  CI  38.7—55.8).
Device-associated infection (DAI) rates
VAP
The  VAP  rate  was  31.8  (95%  CI  19.9—49.8)  per  1000
MV-days  in  the  PICUs  and  73.4  (95%  CI  58.5—90.6)  in
the RICU,  with  an  overall  rate  in  the  3  ICUs  of  59.0
(95% CI  48.1—71.5)  (Table  2).
Cultures were  performed  for  VAP  patients,  and
87.2% showed  growth.  Klebsiella  and  methicillin-
resistant Staphylococcus  aureus  (MRSA)  were  the
most common  microorganisms  associated  with  VAP,
followed by  Pseudomonas  aeruginosa.CLABSI
The CLABSI  rate  was  18.8  per  1000  CL-days  (95%  CI
10.9—29.9)  in  the  PICUs  and  22.5  (95%  CI  14.3—33.6)
a
1
S
lc intensive care unit; ICU, intensive care unit; DA-HAI, device-
tor; UC, urinary catheter; CL, central line.
n the  RICU,  with  an  overall  rate  in  the  3  ICUs  of  20.8
95% CI  14.8—28.2)  (Table  2).
AUTI
he CAUTI  rate  per  1000  UC-days  was  0.0  in  the
ICUs and  34.2  (95%  CI  25.7—44.5)  in  the  RICU,
ith an  overall  rate  in  the  3 ICUs  of  25.4  (95%  CI
9.7—33.2)  (Table  2).
iscussion
lthough  DA-HAIs  have  been  a  primary  and  serious
ause of  patient  morbidity  and  attributable  mor-
ality in  developing  countries  [9—11,13,14,24—27],
his is  the  ﬁrst  multi-center  study  to  show  DA-
AI rates  in  selected  ICUs  in  Egypt.  Furthermore,
A-HAIs have  also  been  considered  to  increase
ealthcare costs  [9,10].  Several  research  studies
onducted  in  the  US  have  indicated  that  the  inci-
ence of  DA-HAIs  can  be  reduced  by  as  much  as
0%, which  would  result  in  accompanying  decreased
ealthcare  costs.  It  is  noteworthy  that  the  studies
arried  out  in  the  US  hospitals  consisted  of  infection
ontrol  programs  that  included  targeted  device-
ssociated  surveillance  [4].
The CLABSI  rate  in  our  PICUs  was  18.8  (95%  CI
0.9—29.9) per  1000  CL-days,  which  is  higher  than
he INICC  report’s  rate  (7.8  per  1000  CL  days  [95%  CI
.1—8.5]) and  the  NHSN  rate  (3.1,  95%  CI  2.5—3.8).
he CLABSI  rate  in  the  respiratory  ICU  was  22.5
95% CI  14.3—33.6),  which  is  higher  than  the  rate  of
.4 in  INICC  medical-surgical  ICUs  (95%  CI  7.2—7.7)
nd much  higher  than  the  NHSN  rate  of  1.5  (95%  CI
.4—1.6). In  a  previous  study  in  a  pediatric  ICU  in
audi Arabia,  the  rate  was  20.06  per  1000  central
ine-days,  which  is  similar  to  our  rate  of  18.8  [28].
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The  VAP  rate  in  our  PICUs  was  31.7  (95%  CI
9.9—49.8) per  1000  MV-days,  which  is  higher  than
he INICC  report’s  rate  (5.5  per  1000  MV-days  [95%  CI
.9—6.0]) and  the  NHSN  rate  (1.8  [95%  CI  1.6—2.1])
3,12]. The  VAP  rate  in  the  respiratory  ICUs  was
3.4 (95%  CI  58.5—90.6),  which  is  higher  than  the
NICC overall  rate  of  14.7  (95%  CI  14.2—15.2)  and
he NHSN  rate  of  1.9  (95%  CI  1.8—2.1).  In  a study
erformed in  an  adult  ICU  in  Kuwait,  VAP  was  the
ost common  infection  at  9.1  per  1000  ventilator-
ays, which  is  lower  than  the  results  in  this  study
29]. The  CAUTI  rate  was  34.2  per  1000  catheter-
ays (95%  CI  25.7—44.5)  in  the  respiratory  ICU,
hich was  also  higher  than  the  INICC  report’s  rate
6.1 per  1000  catheter-days  [95%  CI  5.9—6.4])  and
he NHSN  rate  (3.4  [95%  CI  3.3—3.6])  [3,12].  How-
ver, in  another  study  performed  in  Egypt,  the
AUTI rate  was  15.7  per  1000  catheter-days  (95%  CI
3.4—18.3),  which  is  lower  than  the  results  found
n this  study  [30].
The  overall  hand  hygiene  compliance  rate  was
ower  in  the  PICUs  included  in  this  study  than  in  the
verall INICC  PICUs  (47.1%  [95%  CI  38.7—55.8]  vs.
8.6% [95%  CI  56.3—60.7],  respectively)  [27].
The DA-HAI  rates  shown  in  this  study  can  be
xplained by  several  factors.  In  Egypt,  guidelines
n speciﬁc  infection  control  practices  are  not
dequately adhered  to,  national  infection  control
urveillance  is  not  conducted,  and  hospital  accred-
tation is  not  mandatory.  Similarly,  in  accordance
ith the  explanations  suggested  in  previous  stud-
es conducted  in  hospitals  in  developing  countries,
here is  an  absence  of  legal  regulations  regarding
he implementation  of  infection  control  programs
n most  of  these  countries  [31].  Administrative  and
nancial support  is  lacking,  which  almost  inevitably
esults  in  limited  funds  and  resource  availability  to
ddress infection  control.  Additionally,  it  is  almost
ertain  that  the  low  nurse-to-patient  stafﬁng  ratios
esult in  substantially  high  healthcare-associated
nfection  rates.  In  these  hospitals,  insufﬁcient
upplies, over-crowded  wards  and  antiquated  tech-
ology are  also  among  the  primary  factors  that  can
xplain high  DA-HAI  rates.
The institution  of  DA-HAI  surveillance  is  the  ﬁrst
tep to  reduce  and  systematically  prevent  DA-HAI
isk in  ICU-hospitalized  patients  [4].  Next,  infection
ontrol  practices  need  to  be  adopted  to  improve
he prevention  of  DA-HAIs.  Needless  to  say,  shared
nowledge  and  accurate  information  on  the  bur-
en posed  by  device-associated  infections  in  these
ospital  ICUs  can  serve  to  foster  the  implemen-
ation of  effective  infection  control  strategies  in
eveloping  countries  [32].  In  this  regard,  there
s evidence  suggesting  positive  results  in  health-
are worker  performances.  It has  been  shown  in
t
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ifferent  studies  from  member  hospitals  of  the
NICC that  hand  hygiene  compliance  and  CL,  urinary
atheter  and  ventilator  care  have  improved  con-
iderably  through  the  implementation  of  the  INICC
urveillance  program,  including  performance  feed-
ack for  healthcare  practices  in  the  ICU,  leading  to
 substantial  reduction  in  the  incidence  of  CLABSIs
19,24,33,34], CAUTIs  [21,35]  and  VAP  [18,36—38].
This study  had  many  limitations.  First,  the  data
eported  cannot  be  generalized  for  the  entire  pop-
lation in  Egypt.  From  December  2008  to  July
010, data  from  three  ICUs  in  Egypt  were  recorded
ithin the  comprehensive  surveillance  system  of
he INICC.  A  major  limitation  lies  in  the  possibility
hat the  determined  rates  may  have  been  affected
y slight  variations  in  the  efﬁcacy  of  surveillance
nd resource  availability  for  the  three  hospitals.
imilarly, the  laboratories  involved  may  have  widely
arying levels  of  expertise  and  resource  availabil-
ty. In  this  study,  we  only  had  microorganism  data
rom VAP  infections.  However,  this  is  a  common  fea-
ure that  is  present  in  any  surveillance  study  that
nvolves  different  healthcare  facilities.  Addition-
lly,  the  hospitals  enrolled  in  this  study  initiated
he surveillance  program  at  different  periods,  and
herefore,  data  were  not  simultaneously  collected
rom  the  participating  ICUs.  Finally,  severity  illness
cores, such  as  APACHE,  were  not  applied  because
f the  lack  of  resources  to  calculate  more  labor-
ntensive scores.
onclusions
A-HAIs  present  a  serious  and  largely  under-
ecognized threat  to  patient  safety  in  developing
ountries, which  needs  to  be  faced  imme-
iately. The  INICC  program  provides  health
are personnel  with  simple  but  effective
nd inexpensive  preventive  strategies,  which
ave proved  successful  in  different  studies
18,19,21,24,33—38].
The INICC  network  was  established  to  address
he urgent  need  of  developing  countries  to  signif-
cantly  prevent,  control  and  reduce  DA-HAIs  and
heir adverse  consequences.  We  aim  to  encourage
ider adherence  to  infection  control  programs  in
ll INICC  member  hospitals,  which  will  result  in
ccompanying  and  signiﬁcant  DA-HAI  reductions,
articularly in  the  ICU  setting.  Similar  to  these  hos-
itals in  Egypt,  any  hospital  worldwide  is  invited
o join  the  INICC  program,  through  which  infec-
ion control  teams  are  furnished  with  training,  tools
nd basic  methods  to  conduct  outcome  and  process
urveillance.  Moreover,  through  the  publication  of
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these  conﬁdentially  collected  data,  the  scientiﬁc
evidence-based  literature  is  advanced,  which  also
contributes  to  effectively  and  systematically  tack-
ling this  problem.
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